Fellow of The Academy of Medical Sciences, United Kingdom
Virology, Immunology, Internal medicine, Virus and Acquired immunodeficiency syndrome are his primary areas of study. Pontiano Kaleebu combines subjects such as Drug resistance and Genotype with his study of Virology. The concepts of his Immunology study are interwoven with issues in Observational study, Logistic regression and Risk factor.
His work investigates the relationship between Internal medicine and topics such as Seroconversion that intersect with problems in Hazard ratio and Incidence. Pontiano Kaleebu interconnects V3 loop, Serology, Antigen and ELISPOT in the investigation of issues within Virus. Pontiano Kaleebu has included themes like Young adult, Demography and Cross-sectional study in his Acquired immunodeficiency syndrome study.
Pontiano Kaleebu mainly investigates Virology, Immunology, Internal medicine, Viral load and Acquired immunodeficiency syndrome. Pontiano Kaleebu has researched Virology in several fields, including Drug resistance and Genotype. His study focuses on the intersection of Viral load and fields such as Lamivudine with connections in the field of Nevirapine.
His Acquired immunodeficiency syndrome research incorporates elements of Developing country and Demography. His Virus course of study focuses on Genome and Phylogenetics. His Cohort research focuses on Incidence and how it relates to Cohort study.
Pontiano Kaleebu focuses on Internal medicine, Severe acute respiratory syndrome coronavirus 2, Viral load, Immunology and HIV drug resistance. His studies deal with areas such as Cryptococcal meningitis and Oncology as well as Internal medicine. His Severe acute respiratory syndrome coronavirus 2 research integrates issues from Virus, Genome, Basic reproduction number and 2019-20 coronavirus outbreak.
His Virus research is under the purview of Virology. His biological study spans a wide range of topics, including Biomarker and Cytotoxic T cell. The HIV drug resistance study combines topics in areas such as Dolutegravir and Drug resistance.
His primary scientific interests are in Internal medicine, Genome, Demography, Genetics and Phylogenetics. His research in Internal medicine intersects with topics in Viral load and Antiretroviral therapy. His Viral load study integrates concerns from other disciplines, such as Virological failure, Asymptomatic and Hiv subtypes, Acquired immunodeficiency syndrome.
His study in Demography is interdisciplinary in nature, drawing from both Seroprevalence, Risk factor, Referral and Risk of infection. His study in the field of Recombination, Recombinant DNA and Breakpoint is also linked to topics like Subtyping. His Betacoronavirus study combines topics in areas such as Virus, Virology and Severe acute respiratory syndrome coronavirus 2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso.
Nature Genetics (2013)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do;Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta.
Nature Genetics (2013)
The African Genome Variation Project shapes medical genetics in Africa
Deepti Gurdasani;Tommy Carstensen;Tommy Carstensen;Fasil Tekola-Ayele;Luca Pagani.
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie.
Lancet Infectious Diseases (2017)
Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV-1—Positive Persons in Uganda
Pontiano Kaleebu;Pontiano Kaleebu;Neil French;Cedric Mahe;David Yirrell.
The Journal of Infectious Diseases (2002)
Short-course antiretroviral therapy in primary HIV infection.
S Fidler;K Porter;F Ewings.
The New England Journal of Medicine (2013)
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis
Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor.
PLOS Medicine (2015)
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers.
Lancet Infectious Diseases (2016)
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
Etienne Karita;Nzeera Ketter;Matt A. Price;Kayitesi Kayitenkore.
PLOS ONE (2009)
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh.
Lancet Infectious Diseases (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: